Business
Sundar Pichai
Google CEO Sundar Pichai (Justin Sullivan/Getty Images)

Artificial intelligence is fueling a nuclear renaissance

Google is investing in a nuclear-energy startup to help fuel its AI ambitions.

One of my favorite unexpected developing stories in the artificial-intelligence saga has been the role that AI usage by big tech companies has played in shaping the development of new energy projects in the US. In July, I discussed how in 2021, Google set a goal to reach net-zero emissions by 2030 and reduce its total emissions by 50% compared to a base level of 2019, but in 2023, its emissions had actually increased over the last four years. The reason? “Data center energy consumption and supply chain emissions,” and Google stated that “reducing emissions may be challenging due to increasing energy demands from the greater intensity of AI compute.”

On Monday, The Wall Street Journal reported that Google is taking an interesting approach to addressing this emissions problem: by investing in the construction of new nuclear reactors.

Google will back the construction of seven small nuclear-power reactors in the U.S., a first-of-its-kind deal that aims to help feed the tech company’s growing appetite for electricity to power AI and jump-start a U.S. nuclear revival.

Under the deal’s terms, Google committed to buying power generated by seven reactors to be built by nuclear-energy startup Kairos Power. The agreement targets adding 500 megawatts of nuclear power starting at the end of the decade, the companies said Monday. …

The 500 megawatts of generation that would be built by Kairos for Google is about enough to power a midsize city—or one AI data-center campus.

Google isn’t the first, or even the second, big tech company to agree to a deal like this. Last month, Microsoft signed a deal to restart a nuclear power plant on Three Mile Island, and six months before that, Amazon signed a $650 million deal with Talen Energy to buy nuclear power for an AWS data center.

The logic behind these deals is simple: nuclear energy is roughly four times more efficient than solar, it’s safer than all other forms of energy except solar (and that includes deaths from Chernobyl and Fukushima), and it’s the cleanest form of energy we have, generating just 11% of the emissions of solar. 

Our World in Data Cleanest Energy Sources
Source: Our World in Data

But the up-front costs of building new reactors is expensive, and nuclear still has PR struggles due to, you know, meltdowns at Fukushima, Chernobyl, and Three Mile Island. However, big tech companies have a lot of money to spend (Alphabet, Google’s parent company, had $108 billion of cash and cash equivalents on its balance sheet as of March), and nuclear presents the most readily available path to managing their emissions as they continue to invest in AI infrastructure.

It will be ironic if, 10 years from now, the lasting impact of generative AI wasn’t the content created by LLMs, but the proliferation of nuclear power across the US.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.